Observational studyMedicine2026
Trends in upper respiratory infection burden among children and adolescents in East Asia, 1990 to 2023, with projections to 2035: An observational study based on the Global Burden of Disease 2023.
Observational study in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To evaluate temporal trends in upper respiratory infection (URI) burden among children and adolescents in East Asia from 1990 to 2023 and project trajectories through 2035 using Global Burden of Disease 2023 data. URI incidence, mortality, and disability-adjusted life years (DALYs) for ages 5 to 19 years were extracted for China, DPR of Korea, Japan, Mongolia, Republic of Korea, and globally. Age-standardized rates (age-standardized incidence rate, age-standardized mortality rate, and age-standardized DALYs rate [ASDR]) and estimated annual percentage change were used to assess temporal trends. The socio-demographic index evaluated burden relative to development. Decomposition, age-period-cohort, and Bayesian APC (BAPC) analyses quantified drivers and projected trends through 2035. In 2023, Japan had the highest age-standardized incidence rate (253,071.04 per 100,000) and Mongolia the lowest (105,719.25 per 100,000). Age-standardized mortality rate declined significantly across all countries, most markedly in China (EAPC = -10.97). Burden was greatest at ages 5 to 9 and slightly higher in males. Japan and Republic of Korea showed ASDR substantially exceeding socio-demographic index -expected levels (eff_diff = 43.09 and 37.31). Globally, absolute DALYs increased, driven by population growth and age structure change, partially offset by epidemiological improvement; in East Asian countries, epidemiological improvement was the primary driver of DALYs reduction. Cohort analysis showed generational risk reduction, with a transient period-effect upturn in China during 2019 to 2023. BAPC projections indicate continued global ASDR decline through 2035, rising trends in Japan and Democratic People's Republic of Korea, and a rebound followed by a plateau in China. URI burden among East Asian children and adolescents has broadly declined but with marked country heterogeneity; Japan and Republic of Korea bear a disproportionately high burden relative to their development level, highlighting the need for targeted prevention strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.